In the present work, it was found that lower levels of microRNA-125a were associated with parameters described in the literature to have worse prognosis namely LC/A histology and non-WNT/non-SHH molecular group suggesting a pathogenetic role for microRNA-125a in these tumors. This evidence concerns the gene SHH and laryngotracheoesophageal cleft.